These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8330209)

  • 1. ATP-sensitive potassium channels are not expressed in brain microvessels.
    Sullivan HC; Harik SI
    Brain Res; 1993 May; 612(1-2):336-8. PubMed ID: 8330209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
    Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
    Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mg2+ modulates the binding of [3H]glibenclamide to its receptor in rat cerebral cortical membranes.
    Lee K; Ashford ML
    Eur J Pharmacol; 1993 Nov; 247(3):347-51. PubMed ID: 8307107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels.
    Ashford ML; Boden PR; Treherne JM
    Br J Pharmacol; 1990 Nov; 101(3):531-40. PubMed ID: 2127550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain.
    Zini S; Zini R; Ben-Ari Y
    J Pharmacol Exp Ther; 1993 Feb; 264(2):701-8. PubMed ID: 8437118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermia induced by cholinomimetic drugs is blocked by galanin: possible involvement of ATP-sensitive K+ channels.
    Patel S; Hutson PH
    Eur J Pharmacol; 1994 Apr; 255(1-3):25-32. PubMed ID: 7517882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disopyramide blocks pancreatic ATP-sensitive K+ channels and enhances insulin release.
    Hayashi S; Horie M; Tsuura Y; Ishida H; Okada Y; Seino Y; Sasayama S
    Am J Physiol; 1993 Aug; 265(2 Pt 1):C337-42. PubMed ID: 8368263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.
    Holemans S; Javoy-Agid F; Agid Y; De Paermentier F; Laterre EC; Maloteaux JM
    Brain Res; 1994 Apr; 642(1-2):327-33. PubMed ID: 8032896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of ATP-sensitive K(+) channels in spontaneous activity of isolated lymph microvessels in rats.
    Mizuno R; Ono N; Ohhashi T
    Am J Physiol; 1999 Oct; 277(4):H1453-6. PubMed ID: 10516182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of fluorescein derivatives with glibenclamide binding sites in rat brain.
    Holemans S; Feron O; Octave JN; Maloteaux JM
    Neurosci Lett; 1995 Jan; 183(3):183-6. PubMed ID: 7739789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine activates ATP-sensitive K(+) currents in pericytes of rat retinal microvessels: role of A1 and A2a receptors.
    Li Q; Puro DG
    Brain Res; 2001 Jul; 907(1-2):93-9. PubMed ID: 11430889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]PN200-110 and [3H]glibenclamide binding in normal and cardiomyopathic hamsters.
    Miller JA; Chmielewski PA; Rampe D
    Gen Pharmacol; 1992 Nov; 23(6):1153-7. PubMed ID: 1336750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
    Ningaraj NS; Rao MK; Black KL
    Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glibenclamide upon ATP-sensitive K channels during metabolic inhibition of isolated rat cardiac myocytes.
    Findlay I
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():495-7. PubMed ID: 8251418
    [No Abstract]   [Full Text] [Related]  

  • 15. ATP-sensitive K+ channels.
    Lazdunski M; Allard B; Bernardi H; De Weille J; Fosset M; Heurteaux C; Honoré E
    Ren Physiol Biochem; 1994; 17(3-4):118-20. PubMed ID: 7518937
    [No Abstract]   [Full Text] [Related]  

  • 16. The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed.
    Randall MD; McCulloch AI
    Br J Pharmacol; 1995 Jun; 115(4):607-12. PubMed ID: 7582479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells.
    Ronner P; Hang TL; Kraebber MJ; Higgins TJ
    Br J Pharmacol; 1992 Jun; 106(2):250-5. PubMed ID: 1393260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of glibenclamide analogs: a comparison of potency as levcromakalim antagonists in rat aorta vs. affinity for [3H]-glibenclamide binding to membranes from rat cerebral cortex.
    Challinor-Rogers JL; Kong DC; Iskander MN; McPherson GA
    J Pharmacol Exp Ther; 1995 May; 273(2):778-86. PubMed ID: 7752080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding sites for [3H]glibenclamide in rat liver membranes.
    Inoue Y; Emoto M; Inoue H; Kaku K; Kaneko T
    Eur J Pharmacol; 1995 Sep; 284(1-2):77-82. PubMed ID: 8549639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
    Gopalakrishnan M; Johnson DE; Janis RA; Triggle DJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1162-71. PubMed ID: 1904493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.